mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.09 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.09 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.49 |
0.09 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.47 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |